Peddock Capital Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,896
| Closed | -$983K | – | 249 |
|
|
2019
Q3 | $983K | Sell |
9,896
-1,975
| -17% | -$188K | 0.55% | 42 |
|
|
2019
Q2 | $1.1M | Sell |
11,871
-35
| -0.3% | -$3.32K | 0.58% | 42 |
|
|
2019
Q1 | $1.12M | Sell |
11,906
-272
| -2% | -$23.8K | 0.61% | 35 |
|
|
2018
Q4 | $780K | Sell |
12,178
-1,536
| -11% | -$113K | 0.46% | 47 |
|
|
2018
Q3 | $1.23M | Sell |
13,714
-719
| -5% | -$63.5K | 0.59% | 34 |
|
|
2018
Q2 | $1.15M | Buy |
14,433
+53
| +0.4% | +$4.4K | 0.57% | 34 |
|
|
2018
Q1 | $1.28M | Buy |
14,380
+1,371
| +11% | +$132K | 0.68% | 28 |
|
|
2017
Q4 | $1.36M | Sell |
13,009
-1,295
| -9% | -$146K | 0.68% | 29 |
|
|
2017
Q3 | $2.09M | Buy |
14,304
+73
| +0.5% | +$9.94K | 1.07% | 12 |
|
|
2017
Q2 | $1.85M | Buy |
14,231
+396
| +3% | +$48.5K | 0.98% | 12 |
|
|
2017
Q1 | $1.72M | Buy |
13,835
+684
| +5% | +$81.9K | 0.99% | 13 |
|
|
2016
Q4 | $1.52M | Buy |
13,151
+700
| +6% | +$78K | 0.89% | 15 |
|
|
2016
Q3 | $1.3M | Hold |
12,451
| – | – | 0.8% | 18 |
|
|
2016
Q2 | $1.23M | Buy |
12,451
+61
| +0.5% | +$6.31K | 0.78% | 21 |
|
|
2016
Q1 | $1.24M | Buy |
12,390
+313
| +3% | +$32.2K | 0.94% | 20 |
|
|
2015
Q4 | $1.45M | Buy |
12,077
+378
| +3% | +$43.7K | 1.11% | 14 |
|
|
2015
Q3 | $1.26M | Buy |
11,699
+189
| +2% | +$23.5K | 1.15% | 18 |
|
|
2015
Q2 | $1.33M | Buy |
11,510
+324
| +3% | +$37K | 1.09% | 17 |
|
|
2015
Q1 | $1.29M | Hold |
11,186
| – | – | 1.07% | 15 |
|
|
2014
Q4 | $1.25M | Buy |
11,186
+166
| +2% | +$17.5K | 1.01% | 16 |
|
|
2014
Q3 | $1.04M | Hold |
11,020
| – | – | 0.85% | 26 |
|
|
2014
Q2 | $946K | Buy |
11,020
+248
| +2% | +$18.9K | 0.71% | 34 |
|
|
2014
Q1 | $752K | Buy |
10,772
+842
| +8% | +$66.7K | 0.59% | 36 |
|
|
2013
Q4 | $839K | Buy |
+9,930
| New | +$786K | 0.65% | 36 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Peddock Capital Advisors's CELG Position: Q4 2019 in Review
Peddock Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,896 shares — an estimated $983K sold.
Peddock Capital Advisors first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $2.09M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Peddock Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Peddock Capital Advisors sold 9,896 Celgene Corp shares in Q4 2019, an estimated $983K.
- Peddock Capital Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
- Peddock Capital Advisors's Celgene Corp position peaked at $2.09M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Peddock Capital Advisors's 13F filing for Q4 2019, filed 24 Jan 2020.